Sfoglia per Rivista
Safety and effectiveness of raltegravir in patients with haemophilia and anti-HIV multidrug resistance
2012 L. Mangiafico, M. Perja, F. Fusco, S. Riva, D. Mago, A. Gringeri
Safety and efficacy of combined dual antiplatelet therapy and factor VIII prophylaxis in patients with haemophilia A after acute coronary syndrome
2024 P. Agosti, S.M. Siboni, A. Ciavarella, S. Arcudi, F. Boggio, R. Gualtierotti, F. Peyvandi
Sequential combined bypassing therapy : a rescue option in refractory bleeds – the Italian experience
2008 A. Gringeri, E. Santagostino, M.E. Mancuso, A. Meloni, M. Muça-Perja, S.M. Siboni
Sequential combined bypassing therapy is safe and effective in the treatment of unresponsive bleeding in adults and children with haemophilia and inhibitors
2011 A. Gringeri, K. Fischer, A. Karafoulidou, R. Klamroth, M.F. LÓpez-FernÁndez, M.E. Mancuso
Sequential combined bypassing therapy is safe and effective in the treatment of unresponsive bleeding in adults and children with haemophilia and inhibitors
2010 A. Gringeri, K. Fischer, A. Karafoulidou, R. Klamroth, M. López-Fernández, M. E. Mancuso
Severe acquired von Willebrand syndrome secondary to systemic lupus erythematosus
2019 F. Stufano, L. Baronciani, E. Biguzzi, G. Cozzi, P. Colpani, M. Chisini, F. Peyvandi
SIPPET: methodology, analysis and generalizability
2017 F. Peyvandi, P.M. Mannucci, R. Palla, F.R. Rosendaal
Social adjustment in three cultures : data from families affected by chronic blood disorder. A sibling study
2003 C. Clemente, J. Tsiantis, I. Kolvin, G. Ba, S. Christogiorgos, C. Lee, B. Taylor, R. Miller
Special lectures in haemophilia management
2010 A. Batorova, K.A. High, A. Gringeri
State of the art : von Willebrand disease
2016 A.H. James, J. Eikenboom, A.B. Federici
State of the art of rare bleeding disorders database (RBDD)
2008 M. Spreafico, M. Menegatti, R. Palla, I. Garagiola, L. Tagliabue, A. Cairo, S. Lavoretano, R. Asselta, S. Duga, P.M. Mannucci, F. Peyvandi
The application of bypassing-agent prophylaxis in haemophilia A patients with inhibitors : a meeting report
2009 L. A. Valentino, M. Carcao, P. Mathew, C. A. Leissinger, E. Berntorp, V. Blanchette, C. Escuriola-Ettingshausen, B. Ewenstein, N. Ewing, A. Gringeri, W. K. Hoots, C. Negrier
The correlation between gene mutations and inhibitor development in patients with haemophilia A in southern Iran
2011 S. Haghpanah, M. Sahraiian, A. Afrasiabi, S. Enayati, F. Peyvandi, M. Karimi
The knowledge and perception of factor concentrate in persons with haemophilia A
1995 E. P. Bolivar, R. I. Shopnick, P. M. Mannucci, A. Gringeri, D. B. Brettler
The spectrum of factor XI deficiency in Italy
2013 G. Castaman, S.H. Giacomelli, S. Caccia, F. Riccardi, G. Rossetti, A. Dragani, A.C. Giuffrida, C. Biasoli, S. Duga
Third Åland islands conference on von Willebrand disease, 26-28 September 2012 : meeting report
2013 E. Berntorp, B. Fuchs, M. Makris, R. Montgomery, V. Flood, J.S. O'Donnell, A.B. Federici, D. Lillicrap, P. James, U. Budde, M. Morfini, P. Petrini, S. Austin, C. Kannicht, V. Jiménez Yuste, C. Lee
The thrombin generation assay distinguishes inhibitor from non-inhibitor patients with severe haemophilia A
2016 M. Mancuso, V. Chantarangkul, M. Clerici, M. Fasulo, L. Padovan, E. Scalambrino, F. Peyvandi, A. Tripodi, E. Santagostino
Treatment for patients with type 3 von Willebrand disease and alloantibodies : a case report
2008 M. Franchini, G. Gandini, A. Giuffrida, M. De Gironcoli, A.B. Federici
Treatment protocol of haemophilia and other congenital bleeding disorders in Italy
1998 A. Gringeri, Italian Association of Hemophilia Centers (AICE)
Two adjacent homozygous mutations on EGF2 domain of factor X (FX) gene lead to severe FX deficiency
2006 M. Menegatti, R. Palla, F. Peyvandi
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile